These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
25. Pharmacology of different progestogens: the special case of drospirenone. Sitruk-Ware R Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650 [TBL] [Abstract][Full Text] [Related]
26. [Oral contraception: evolution of concepts over the last thirty years]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408 [TBL] [Abstract][Full Text] [Related]
27. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
28. The use of newer progestins for contraception. Sitruk-Ware R; Nath A Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114 [TBL] [Abstract][Full Text] [Related]
32. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. El-Ibiary SY; Cocohoba JM Eur J Contracept Reprod Health Care; 2008 Jun; 13(2):123-32. PubMed ID: 18465473 [TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Africander D; Verhoog N; Hapgood JP Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337 [TBL] [Abstract][Full Text] [Related]
38. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. Bradley DD; Wingerd J; Petitti DB; Krauss RM; Ramcharan S N Engl J Med; 1978 Jul; 299(1):17-20. PubMed ID: 207983 [TBL] [Abstract][Full Text] [Related]
39. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies. Burkman RT Am J Manag Care; 2001 Nov; 7(18 Suppl):S571-4. PubMed ID: 11727395 [TBL] [Abstract][Full Text] [Related]
40. [Oral contraceptives and thromboembolism (author's transl)]. Sato K; Ogino M; Nakabayashi M; Sakamoto S Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]